<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="covid_vaccine/PMC7467145/results/search/disease/results.xml">
  <result pre="(antiviral: guanine derivative) RdRp Inhibit RNA polymerization (1) RSV infection," exact="hepatitis" post="C, some viral hemorrhagic fevers (2) In case of"/>
  <result pre="underway Oseltamivir [66] (antiviral) Neuraminidase enzyme Inhibits neuraminidase enzyme in" exact="influenza" post="Used in influenza patient. This drug is used for"/>
  <result pre="(antiviral) Neuraminidase enzyme Inhibits neuraminidase enzyme in influenza Used in" exact="influenza" post="patient. This drug is used for repurposing only in"/>
  <result pre="(2) Inhibits viral-host cell fusion (1) An antiviral treatment for" exact="influenza" post="infection used in Russia and China (2) Proposed reduction"/>
  <result pre="been proven effective in treating coronavirus in China (2) Treating" exact="pneumonia" post="patients with SARS-CoV-2 infection Approved for clinical trial against"/>
  <result pre="inhibitor (JAK) Affects the inflammatory processes (1) Approved drug for" exact="rheumatoid arthritis" post="(2) Used to treat acute respiratory disease in COVID-19"/>
  <result pre="(JAK) Affects the inflammatory processes (1) Approved drug for rheumatoid" exact="arthritis" post="(2) Used to treat acute respiratory disease in COVID-19"/>
  <result pre="Approved drug for rheumatoid arthritis (2) Used to treat acute" exact="respiratory disease" post="in COVID-19 patients Eli Lilly has announced plans to"/>
  <result pre="initiate parallel prospective, interventional studies with mavrilimumab in patients with" exact="pneumonia" post="and hyper-inflammation caused by SARS-Cov-2. Kiniksa also reported that"/>
  <result pre="therapy. It can aid cytokine-mediated immunopathology of lung injury and" exact="acute respiratory distress syndrome" post="(ARDS) On 2 April 2020, FDA authorized the use"/>
  <result pre="with lenzilumab for the prevention of ARDS in patients with" exact="pneumonia" post="caused by SARS-CoV-2 Leronlimab [75] (monoclonal antibody) CytoDyn (as"/>
  <result pre="can be used for the treatment of CCR5-positive metastatic triple-negative" exact="breast cancer." post="It is also used in antiretroviral therapy (HAART) in"/>
  <result pre="(PD-1) Programmed cell death 1 (PD-1) inhibitor (1) Classical Hodgkin" exact="lymphoma" post="(2) Treat pneumonia (3) Sepsis Phase-II clinical trials (NCT04268537)"/>
  <result pre="death 1 (PD-1) inhibitor (1) Classical Hodgkin lymphoma (2) Treat" exact="pneumonia" post="(3) Sepsis Phase-II clinical trials (NCT04268537) Eculizumab [Soliris] [81]"/>
  <result pre="for acute lung injury (ALI) and/or ARDS in COVID-19 through" exact="suppression" post="of pulmonary edema Under clinical trial (NCT04275414) Bevacizumab, an"/>
  <result pre="lung injury (ALI) and/or ARDS in COVID-19 through suppression of" exact="pulmonary edema" post="Under clinical trial (NCT04275414) Bevacizumab, an anti-VEGF drug, approved"/>
  <result pre="cytokines Used for the treatment of graft-versus-host disease (GVHD) in" exact="leukemia" post="patients receiving hematopoietic stem cell transplantation OncoImmune is planning"/>
  <result pre="to treat COVID-19 induced ARDS. Used for heart attacks or" exact="stroke" post="Under clinical trial. A recent report suggested that the"/>
  <result pre="processes by the inhibition of TNF alpha Effective against COVID-19" exact="pneumonia" post="Under clinical trials (NCT04323514) Box 1 Miscellaneous therapeutics under"/>
  <result pre="protease inhibitor), Ritonavir and interferon (approved in China to treat" exact="hepatitis" post="C, developed by Ascletis; clinical stage), ASC09 (HIV protease"/>
  <result pre="fusion, thus preventing the viral entry into host cells against" exact="influenza" post="virus [37–39]. Camostat mesylate The serine protease TMPRSS2 produced"/>
  <result pre="is also able to inhibit virus infection proficiently in human" exact="liver cancer" post="Huh-7 cells sensitive to COVID-19. A recent case study"/>
  <result pre="also able to inhibit virus infection proficiently in human liver" exact="cancer" post="Huh-7 cells sensitive to COVID-19. A recent case study"/>
  <result pre="available, this drug is able to inhibit the exacerbation of" exact="pneumonia" post="patients with SARS-CoV-2 infection. Fig. 8 Schematic representation of"/>
  <result pre="for manufacturing and sale in Japan for the treatment of" exact="influenza" post="as an antiviral. In case of Influenza virus, it"/>
  <result pre="treatment benefit.&quot; Among those trials, two trials are investigating against" exact="pneumonia" post="caused by COVID-19. One trial is conducted in the"/>
  <result pre="and ventricular arrhythmias), Ear and labyrinth disorders, Eye disorders (Irreversible" exact="retinopathy" post="with retinal pigmentation changes), maculopathies (macular degeneration), decreased dark"/>
  <result pre="inducer Mild: Gastrointestinal disorders Serious: Hyperlipidemia, cardiac conduction disorders, hepatotoxicity," exact="pancreatitis" post="Losartan [34] Initial dose: 50 mg orally once a"/>
  <result pre="benazepril/lisinopril, birth control pills containing drospirenone Mild: Dizziness, chest pain," exact="hypoglycemia" post="Serious: Hyperkalemia, hypotension, and orthostatic hypotension Remdesivir [14, 57–59,"/>
  <result pre="tuberculosis), headache, nasopharyngitis, hypertension Serious: Gastrointestinal perforations, hematologic effects, hepatotoxicity," exact="hypersensitivity" post="reactions Umifenovir (Arbidol) [38, 39, 89] 200 mg every"/>
  <result pre="in the market. It is made from live, attenuated bovine" exact="tuberculosis" post="bacillus, Mycobacterium bovis which induces an adaptive immune response"/>
  <result pre="bacillus, Mycobacterium bovis which induces an adaptive immune response against" exact="tuberculosis" post="bacterium. Due to availability in the market, they utilize"/>
  <result pre="declare. References References 1.WuFZhaoSYuBet al.A new coronavirus associated with human" exact="respiratory disease" post="in ChinaNature202057926526932015508 2.ZhouPYangX-LWangX-Get al.A pneumonia outbreak associated with a"/>
  <result pre="coronavirus associated with human respiratory disease in ChinaNature202057926526932015508 2.ZhouPYangX-LWangX-Get al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="Microbiol Infect Dis20183736336929214503 5.ZhuNZhangDWangWet al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773331978945 6.LiXZaiJWangXLiYPotential of large"/>
  <result pre="of optimized dosing design of hydroxychloroquine for the treatment of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2)Clin Infect Dis202010.1093/cid/ciaa23732857833 12.FantiniJDi ScalaCChahinianHYahiNStructural and molecular"/>
  <result pre="35.GlowackaIBertramSHerzogPet al.Differential downregulation of ACE2 by the spike proteins of" exact="severe acute respiratory syndrome" post="coronavirus and human coronavirus NL63J Virol2010841198120519864379 36.WuYCompensation of ACE2"/>
  <result pre="ClinicalTrials.gov website: https://clinicaltrials.gov/ct2/show/NCT04252885. Accessed 11 May 2020 39.KadamRUWilsonIAStructural basis of" exact="influenza" post="virus fusion inhibition by the antiviral drug ArbidolProc Natl"/>
  <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci Trends202014727332074550 44.Al-BariMAATargeting endosomal acidification by chloroquine"/>
  <result pre="to test coronavirus treatmentsNature202057834734832071447 46.MifsudEJHaydenFGHurtACAntivirals targeting the polymerase complex of" exact="influenza" post="virusesAntivir Res201916910454531247246 47.LiuXWangXJPotential inhibitors against 2019-nCoV coronavirus M protease"/>
  <result pre="trial to assess common anti-clotting medication for treatment of COVID-19-related" exact="respiratory failure." post="BIDMC. https://www.bidmc.org/about-bidmc/news/2020/04/covid-19-anti-clotting-medication. Accessed 11 May 2020 87.Clinical management of"/>
 </snippets>
</snippetsTree>
